Afucosylated IgG Targets FcγRIV for Enhanced Tumor Therapy in Mice

SIMPLE SUMMARY: Cancer treatments are increasingly based on therapeutic antibodies to clear tumors. While in vivo mouse models are useful to predict effectiveness of human antibodies it is not completely clear how useful these models are to test antibodies engineered with enhanced effector functions...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Braster, Rens, Bögels, Marijn, Benonisson, Hreinn, Wuhrer, Manfred, Plomp, Rosina, Bentlage, Arthur E. H., Korthouwer, Rianne, Visser, Remco, Verbeek, J. Sjef, van Egmond, Marjolein, Vidarsson, Gestur
Aineistotyyppi: Online Artikkeli Teksti
Kieli:English
Julkaistu: MDPI 2021
Aiheet:
Article
Linkit:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156657/
https://www.ncbi.nlm.nih.gov/pubmed/34069226
http://dx.doi.org/10.3390/cancers13102372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156657/
https://www.ncbi.nlm.nih.gov/pubmed/34069226
http://dx.doi.org/10.3390/cancers13102372

Samankaltaisia teoksia